Strategies to overcome the limitations of AIEgens in biomedical applications

Motivated by the demand for high‐performance tools for biomedical applications, numerous new luminescent nanomaterials with advanced functionalities are synthesized in recent years. Conventional fluorophores generally suffer from the notorious aggregation‐caused quenching effect that deteriorates th...

Full description

Saved in:
Bibliographic Details
Main Authors: Gu, Bobo, Yong, Ken-Tye, Liu, Bin
Other Authors: School of Electrical and Electronic Engineering
Format: Article
Language:English
Published: 2020
Subjects:
Online Access:https://hdl.handle.net/10356/138472
Tags: Add Tag
No Tags, Be the first to tag this record!
Institution: Nanyang Technological University
Language: English
id sg-ntu-dr.10356-138472
record_format dspace
spelling sg-ntu-dr.10356-1384722020-05-06T08:48:21Z Strategies to overcome the limitations of AIEgens in biomedical applications Gu, Bobo Yong, Ken-Tye Liu, Bin School of Electrical and Electronic Engineering Engineering::Electrical and electronic engineering Aggregation-Induced Emission Nanocrystallization Motivated by the demand for high‐performance tools for biomedical applications, numerous new luminescent nanomaterials with advanced functionalities are synthesized in recent years. Conventional fluorophores generally suffer from the notorious aggregation‐caused quenching effect that deteriorates their practical performance. The recently emerged fluorogens with aggregation‐induced emission (AIE) characteristics (AIEgen) have generated a new avenue for biomedical applications due to their unique optical properties, flexible designability, and multifunctional potential. However, the inherent characteristics of AIEgens, including short wavelength absorption, broad emission, and aggregation‐dependent brightness indirectly limit their practical performance in the biomedical field. Here, the recent development of AIEgens for biomedical applications is summarized and novel strategies to overcome their limitations are proposed. Furthermore, the strategies and guidelines for the rational design of AIEgens, preparation of water‐dispersible AIE nanoparticles, and selection of the excitation/emission methods, which enable AIEgens to be useful in a broader range of biomedical applications, are discussed. NRF (Natl Research Foundation, S’pore) ASTAR (Agency for Sci., Tech. and Research, S’pore) 2020-05-06T08:48:21Z 2020-05-06T08:48:21Z 2018 Journal Article Gu, B., Yong, K.-T., & Liu, B. (2018). Strategies to overcome the limitations of AIEgens in biomedical applications. Small Methods, 2(9), 1700392-. doi:10.1002/smtd.201700392 2366-9608 https://hdl.handle.net/10356/138472 10.1002/smtd.201700392 9 2 en Small Methods © 2018 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim. All rights reserved.
institution Nanyang Technological University
building NTU Library
country Singapore
collection DR-NTU
language English
topic Engineering::Electrical and electronic engineering
Aggregation-Induced Emission
Nanocrystallization
spellingShingle Engineering::Electrical and electronic engineering
Aggregation-Induced Emission
Nanocrystallization
Gu, Bobo
Yong, Ken-Tye
Liu, Bin
Strategies to overcome the limitations of AIEgens in biomedical applications
description Motivated by the demand for high‐performance tools for biomedical applications, numerous new luminescent nanomaterials with advanced functionalities are synthesized in recent years. Conventional fluorophores generally suffer from the notorious aggregation‐caused quenching effect that deteriorates their practical performance. The recently emerged fluorogens with aggregation‐induced emission (AIE) characteristics (AIEgen) have generated a new avenue for biomedical applications due to their unique optical properties, flexible designability, and multifunctional potential. However, the inherent characteristics of AIEgens, including short wavelength absorption, broad emission, and aggregation‐dependent brightness indirectly limit their practical performance in the biomedical field. Here, the recent development of AIEgens for biomedical applications is summarized and novel strategies to overcome their limitations are proposed. Furthermore, the strategies and guidelines for the rational design of AIEgens, preparation of water‐dispersible AIE nanoparticles, and selection of the excitation/emission methods, which enable AIEgens to be useful in a broader range of biomedical applications, are discussed.
author2 School of Electrical and Electronic Engineering
author_facet School of Electrical and Electronic Engineering
Gu, Bobo
Yong, Ken-Tye
Liu, Bin
format Article
author Gu, Bobo
Yong, Ken-Tye
Liu, Bin
author_sort Gu, Bobo
title Strategies to overcome the limitations of AIEgens in biomedical applications
title_short Strategies to overcome the limitations of AIEgens in biomedical applications
title_full Strategies to overcome the limitations of AIEgens in biomedical applications
title_fullStr Strategies to overcome the limitations of AIEgens in biomedical applications
title_full_unstemmed Strategies to overcome the limitations of AIEgens in biomedical applications
title_sort strategies to overcome the limitations of aiegens in biomedical applications
publishDate 2020
url https://hdl.handle.net/10356/138472
_version_ 1681057048812322816